| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 6 | | | |
| | | | 17 | | | |
| | | | 17 | | | |
| | | | 18 | | | |
| | | | 19 | | | |
| | | | 26 | | | |
| | | | 31 | | | |
| | | | 32 | | | |
| | | | 33 | | | |
| | | | 34 | | | |
| | | | A-1 | | | |
| | | | B-1 | | |
Proposal
|
| |
Vote Required
|
|
PROPOSAL 1 : Election of Directors | | | A plurality of the votes cast | |
PROPOSAL 2: Ratification of Weinberg & Company, P.A. as independent registered public accounting firm | | | A majority of the votes cast | |
PROPOSAL 3: Approve the Guardion Health Sciences, Inc. 2018 Equity Incentive Plan | | | A majority of the votes cast | |
PROPOSAL 4 : Approval of the Reverse Stock Split Proposal | | | A majority of the Company’s outstanding Common Stock | |
PROPOSAL 5: Advisory Vote on Executive Compensation | | | A majority of the votes cast | |
PROPOSAL 6: Advisory Vote on Frequency of Say-On-Pay Votes | | | A majority of the votes cast | |
PROPOSAL 7: Adjournment of the Annual Meeting, if Necessary or Appropriate | | | A majority of the votes cast | |
Name of Beneficial Owner and Title of Officers and Directors
|
| |
Shares of
Common Stock Beneficially Owned |
| |
Percentage of
Common Stock Beneficially Owned |
| ||||||
Michael Favish, Chief Executive Officer, President and Director
(a)
|
| | | | 6,494,933 | | | | | | 16.10 % | | |
Robert N. Weingarten, Director
|
| | | | 1,300,000 | | | | | | 3.22 % | | |
Mark Goldstone, Director
|
| | | | 1,050,000 | | | | | | 2.60 % | | |
David Evans, Director
(b)
|
| | | | 3,050,000 | | | | | | 7.56 % | | |
John Townsend, Chief Accounting Officer and Controller
|
| | | | 105,000 | | | | | | 0.26 % | | |
Vincent J. Roth, General Counsel and Corporate Secretary
|
| | | | 265,000 | | | | | | 0.66 % | | |
All Officers and Directors as a Group (6 persons)
(c)
|
| | | | 12,264,933 | | | | | | 30.41 % | | |
5% Stockholders: | | | | ||||||||||
Leon Krajian
(d)
|
| | | | 3,617,569 | | | | | | 8.74 % | | |
Digital Grid (Hong Kong) Technology Co., Limited
(e)
|
| | | | 4,347,827 | | | | | | 10.78 % | | |
Christopher Scangas
(f)
|
| | | | 2,608,489 | | | | | | 6.46 % | | |
Edward Grier
|
| | | | 2,158,178 | | | | | | 5.31 % | | |
Name
|
| |
Age
|
| |
Position
|
|
Michael Favish | | |
70
|
| | President, Chief Executive Officer and Chairman of the Board of Directors | |
Robert Weingarten | | |
66
|
| | Director, Lead Director | |
Mark Goldstone | | |
56
|
| | Director | |
David W. Evans | | |
62
|
| | Director, Chief Science Officer | |
John Townsend | | |
57
|
| | Controller, Chief Accounting Officer | |
Vincent J. Roth | | |
50
|
| | General Counsel and Corporate Secretary | |
Executive
|
| |
Year
|
| |
Salary
|
| |
Bonus
|
| |
Stock Awards
|
| |
All Other
Compensation |
| |
Total
|
| |||||||||||||||
Michael Favish
(1)
|
| |
2017
|
| | | $ | 250,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 250,000 | | |
|
2016
|
| | | $ | 250,000 | | | | | $ | — | | | | | $ | 4,500 | | | | | $ | — | | | | | $ | 254,500 | | | ||
Gordon Bethwaite
(2)
|
| |
2017
|
| | | $ | 208,800 | | | | | $ | 15,000 | | | | | $ | — | | | | | $ | — | | | | | $ | 223,800 | | |
|
2016
|
| | | $ | 208,800 | | | | | $ | — | | | | | $ | 1,800 | | | | | $ | — | | | | | $ | 210,600 | | | ||
John Townsend
(3)
|
| |
2017
|
| | | $ | 144,000 | | | | | $ | 10,000 | | | | | $ | 9,000 | | | | | $ | — | | | | | $ | 163,000 | | |
|
2016
|
| | | $ | 68,000 | | | | | $ | — | | | | | $ | 450 | | | | | $ | — | | | | | $ | 68,450 | | |
Director
|
| |
Year
|
| |
Stock
Awards (1) |
| |
Fees Earned or
Paid in Cash |
| |
Total
|
| |||||||||
Mark Goldstone
|
| |
2017
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | |
|
2016
|
| | | $ | 4,500 | | | | | $ | — | | | | | $ | 4,500 | | | ||
Robert Weingarten
|
| |
2017
|
| | | $ | — | | | | | $ | 60,000 (2) | | | | | $ | 60,000 | | |
|
2016
|
| | | $ | 4,500 | | | | | $ | — | | | | | $ | 4,500 | | | ||
David W. Evans
|
| |
2017
|
| | | $ | — | | | | | $ | 30,000 (3) | | | | | $ | 30,000 | | |
|
2016
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | |
Plan Category
|
| |
Number of Securities to be
Issued Upon Exercise of Outstanding Options, Warrants, and Rights |
| |
Weighted Average
Exercise Price of Outstanding Options, Warrants, and Rights |
| |
Number of Securities Remaining
Available For Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in the First Column) |
| |||||||||
Equity compensation plans approved by security holders:
|
| | | | | | | | | | | | | | | | | | |
| | | | | — | | | | | $ | — | | | | | | — | | |
Equity compensation plans not approved by security holders:
|
| | | | | | | | | | | | | | | | | | |
| | | | | 2,125,000 | | | | | $ | 1.10 | | | | | | — | | |
Total
|
| | | | 2,125,000 | | | | | $ | 1.10 | | | | | | — | | |